Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. (VNDA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · VNDA · as of Jun 9, 2026
Activity summary
Buy transactions
4
P-Purchase only
Sell transactions
7
12 Months
Buy/Sell ratio
0.57
Buy/Sell (by trades)
Overall sentiment
Vanda Pharmaceuticals Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
VNDA insider buying and selling by quarter
VNDA insider selling · VNDA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · VNDA ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
VNDA executive sell shares · VNDA board member insider trading · VNDA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 4, 2026 | McGuire Daniel Patrick SVP, GC and Secretary | Award | 80,000 | — | Form 4 |
| Jun 4, 2026 | Chrousos Phaedra Director | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | Duncan Charles Cliff Director | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | DUGAN RICHARD W Director | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | Ward Anne Sempowski Director | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | Honore Tage Director | Award | 41,600 | — | Form 4 |
| Jun 4, 2026 | Mitchell Stephen Ray Director | Award | 41,600 | — | Form 4 |
| May 18, 2026 | Mitchell Stephen Ray Director | Gift | 25,836 | — | Form 4 |
| Apr 22, 2026 | Duncan Charles Cliff Director | Award | 57,101 | — | Form 4 |
| Mar 2, 2026 | Williams Timothy SVP & General Counsel | Sale | 42,434 | $351K | Form 4 |
| Mar 2, 2026 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | 42,442 | $351K | Form 4 |
| Mar 2, 2026 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | 30,800 | $255K | Form 4 |
| Mar 2, 2026 | Polymeropoulos Mihael Hristos Director | Sale | 156,235 | $1.28M⚡ | Form 4 |
| Mar 2, 2026 | Birznieks Gunther SVP, Business Development | Sale | 42,431 | $351K | Form 4 |
| Feb 23, 2026 | Honore Tage Director | Sale | 30,000 | $241K | Form 4 |
| Feb 18, 2026 | Wijkstrom Joakim SVP, Chief Marketing Officer | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Birznieks Gunther SVP, Business Development | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Williams Timothy SVP & General Counsel | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Moran Kevin Patrick SVP, CFO & Treasurer | Award | 125,000 | — | Form 4 |
| Feb 18, 2026 | Polymeropoulos Mihael Hristos Director | Award | 525,000 | — | Form 4 |
| Aug 7, 2025 | Polymeropoulos Mihael Hristos Director | Purchase | 10,000 | $42K | Form 4 |
| Jun 13, 2025 | Mitchell Stephen Ray Director | Sale | 7,000 | $32K | Form 4 |
| Jun 5, 2025 | Mitchell Stephen Ray Director | Award | 59,225 | — | Form 4 |
| Jun 5, 2025 | Chrousos Phaedra Director | Award | 59,225 | — | Form 4 |
| Jun 5, 2025 | DUGAN RICHARD W Director | Award | 59,225 | — | Form 4 |
McGuire Daniel Patrick
SVP, GC and Secretary
Date
Jun 4
Shares
80,000
Price
—
Value
—
Williams Timothy
SVP & General Counsel
Date
Mar 2
Shares
42,434
Price
$8.27
Value
$351K
Moran Kevin Patrick
SVP, CFO & Treasurer
Date
Mar 2
Shares
42,442
Price
$8.27
Value
$351K
Wijkstrom Joakim
SVP, Chief Marketing Officer
Date
Mar 2
Shares
30,800
Price
$8.27
Value
$255K
Polymeropoulos Mihael Hristos
Director
Date
Mar 2
Shares
156,235
Price
$8.17
Value
$1.28M ⚡
Birznieks Gunther
SVP, Business Development
Date
Mar 2
Shares
42,431
Price
$8.27
Value
$351K
Wijkstrom Joakim
SVP, Chief Marketing Officer
Date
Feb 18
Shares
125,000
Price
—
Value
—
Birznieks Gunther
SVP, Business Development
Date
Feb 18
Shares
125,000
Price
—
Value
—
Moran Kevin Patrick
SVP, CFO & Treasurer
Date
Feb 18
Shares
125,000
Price
—
Value
—
Polymeropoulos Mihael Hristos
Director
Date
Aug 7
Shares
10,000
Price
$4.15
Value
$42K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About VNDA insider trading
VNDA insider trades
Vanda Pharmaceuticals Inc. (VNDA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Mitchell Stephen Ray (Director), Polymeropoulos Mihael Hristos (Director), Duncan Charles Cliff (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. VNDA insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Vanda Pharmaceuticals Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
VNDA insider trading · 5 questionsThe insiders of Vanda Pharmaceuticals Inc. (VNDA) include executives and directors such as Mitchell Stephen Ray (Director), Polymeropoulos Mihael Hristos (Director), Duncan Charles Cliff (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026